News

News

HomeNews
Company NewsIndustry News
[First Release] KATI Medical completed the A+ round of financing of over 70 million ¥, and accelerated the IND application and pipeline development of leading products

[First Release] KATI Medical completed the A+ round of financing of over 70 million ¥, and accelerated the IND application and pipeline development of leading products

2022, Nanjing KATI Medical Technology Co., Ltd. (hereinafter referred to as Nanjing KATI), a new domestic solid tumor CAR-T cell therapy company, completed a total of more than 70 million ¥ in A+ round of financing

2022-04-01
Nanjing Kati Medical Technology Co., Ltd. won the first prize of the 2020

Nanjing Kati Medical Technology Co., Ltd. won the first prize of the 2020 "Win in Nanjing Entrepreneurship Jinling" Technology Innovation and Entrepreneurship Competition

Nanjing Kati Medical Technology Co., Ltd. won the first prize of the 2020 "Win in Nanjing Entrepreneurship Jinling" Technology Innovation and Entrepreneurship Competition

2020-11-30
The 2020 Nanjing International Life and Health Technology Conference and Expo ended successfully!

The 2020 Nanjing International Life and Health Technology Conference and Expo ended successfully!

"Technology leads a healthy future"2020 Nanjing International Life and Health Technology ExpoFinished perfectly!
Katy Medical has successfully concluded!

2020-12-11
Good news! Nanjing Kati Medicine successfully passed the national high-tech enterprise certification

Good news! Nanjing Kati Medicine successfully passed the national high-tech enterprise certification

Good news! Nanjing Kati Medicine successfully passed the national high-tech enterprise certification

2020-12-01
Good news! Kati won the

Good news! Kati won the "Second Prize" in the "Entrepreneurship Jiangsu" competition

Good news! Katy won the "Second Prize" in the "Entrepreneurship Jiangsu" competition

2020-12-01